ACTH 1-13

ACTH (1-13) is a 13-aa peptide, with cytoprotective effects in the model of ethanol induced gastric lesions in rats.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.

CAT No: R1153

CAS No:22006-64-0

Synonyms/Alias:Adrenocorticotropic Hormone (1-13)

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.F/Formula
C₇₅H₁₀₆N₂₀O₁₉S
M.W/Mr.
1623.83
Sequence
One Letter Code: SYSMEHFRWGKPV
three Letter Code: Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val

ACTH 1-13, also known as Adrenocorticotropic Hormone (1-13), is a synthetic peptide fragment corresponding to the N-terminal sequence of the full-length ACTH molecule. As a bioactive peptide, ACTH 1-13 represents the initial segment of the endogenous hormone produced by the anterior pituitary gland, which plays a pivotal role in the regulation of adrenal steroidogenesis. The sequence encompasses the region responsible for receptor interaction and partial biological activity, making it a valuable tool for peptide research, structure-activity relationship studies, and investigations into the mechanisms of hormone signaling. Its defined structure and functional relevance position it as a critical reagent in neuroendocrinology, peptide biochemistry, and molecular pharmacology.

Peptide signaling research: ACTH 1-13 is widely utilized in studies aimed at elucidating the mechanisms of peptide-receptor interactions within the melanocortin receptor family. By isolating the N-terminal domain, researchers can dissect the contribution of this segment to receptor binding affinity and specificity. Employing this fragment enables detailed mapping of critical residues involved in receptor activation, facilitating a deeper understanding of how truncated peptides modulate cellular responses compared to the full-length hormone.

Structure-activity relationship analysis: The 1-13 fragment serves as an essential reference point for investigating the minimal sequence requirements for biological activity in ACTH-derived peptides. Through comparative assays using truncated and modified analogs, scientists can systematically evaluate how sequence alterations affect potency, efficacy, and selectivity. Insights gained from these studies inform the rational design of novel peptide analogs with tailored pharmacological profiles for basic research applications.

Neuroendocrine pathway modeling: In neuroendocrinological research, ACTH 1-13 is employed to model the upstream events of hypothalamic-pituitary-adrenal (HPA) axis signaling. Its application in cell-based and in vitro systems enables the dissection of early events in ACTH-mediated signal transduction, such as cAMP accumulation and downstream effector activation. Such models are instrumental in characterizing receptor subtypes, identifying novel signaling intermediates, and delineating the functional consequences of selective receptor engagement.

Peptide synthesis and analytical validation: The defined sequence of ACTH 1-13 makes it a useful standard in peptide synthesis, purification, and analytical method development. It is often used as a reference compound for optimizing chromatographic separation, mass spectrometric detection, and quantification protocols. The availability of this fragment supports quality control processes and facilitates the benchmarking of synthetic methodologies in peptide chemistry laboratories.

Immunoassay development: The epitope-rich N-terminal region of ACTH is frequently targeted in the design and optimization of immunoassays for peptide quantitation. ACTH 1-13 serves as a calibrator or antigen in the development of antibody-based detection systems, enabling the generation of highly specific reagents for research use. Its application aids in the establishment of sensitive and selective assays for monitoring peptide hormone levels in experimental samples, supporting a wide range of studies in endocrinology and molecular diagnostics.

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
cGMP Peptide ServicePeptide Synthesis ServicesCustom Conjugation ServicePeptide Nucleic Acids SynthesisEpitope Mapping ServicesPeptide CDMOPeptide Analysis ServicesPeptide Modification Services
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers